Gainesville, FL, United States of America

Brian E Szente

This inventor holds 2 USPTO granted patents. Top assignee: University of Florida Research Foundation Inc.. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian E Szente. Retrieved from https://idiyas.com/inventor/brian-e-szente

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brian E Szente: Innovator in Interferon Peptides

Introduction

Brian E Szente is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel peptides derived from gamma interferon. His work has implications for various therapeutic applications.

Latest Patents

Brian E Szente holds 2 patents related to C-terminal peptides of interferon gamma. His latest patents include "C-terminal peptides of interferon .gamma." and "Active C-terminal peptides of interferon--gamma and their use." Both inventions focus on novel peptides from the C-terminus of gamma interferon (IFN.gamma.) and their biological activity, which is comparable to the full-length IFN.gamma. protein once internalized into a cell.

Career Highlights

Brian is associated with the University of Florida Research Foundation Inc., where he continues to advance research in his field. His innovative work has garnered attention and recognition within the scientific community.

Collaborations

Brian E Szente collaborates with Howard Marcellus Johnson, contributing to the advancement of research in biotechnology and peptide development.

Conclusion

Brian E Szente's contributions to the field of interferon peptides highlight his role as an innovator in biotechnology. His patents reflect significant advancements that may lead to new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…